title: Verapamil attenuates lung vascular responses to endotoxin in sheep.
abstract: Experiments were conducted on five chronically instrumented unanesthetized sheep to determine the effects of verapamil, a calcium channel inhibitor, on the pulmonary hemodynamic and microvascular permeability responses to endotoxemia. Paired control endotoxemia experiments (E) and endotoxemia with verapamil treatment (30-60 micrograms.kg-1.min-1) experiments (V + E) were conducted on each sheep in random order. In the V + E experiments sheep were pretreated with a continuous intravenous infusion of verapamil 1.5-2.0 h before endotoxin infusion (1.0 microgram/kg, given over 15 min). Verapamil significantly increased base-line pulmonary arterial pressure, left atrial pressure, lung lymph flow rate, and circulating blood leukocyte levels and significantly decreased base-line cardiac output. During the endotoxin response, verapamil significantly attenuated both phase I pulmonary arterial hypertension and phase II lung lymph flow rate compared with control endotoxin experiments. The results indicate that verapamil attenuates both the pulmonary hemodynamic and increased lung microvascular permeability response to endotoxin in sheep. In a series of in vitro experiments, verapamil was found to be a potent inhibitor of phorbol myristate acetate-induced superoxide production in isolated sheep granulocytes. These data suggest that the beneficial in vivo effects of verapamil during endotoxemia may in part be due to its inhibition of increased free cytosol calcium concentration and/or inhibition of toxic O2 metabolite production.
authors.affiliation: Pulmonary Circulation Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
authors.forename: R E
authors.initials: RE
authors.lastname: Parker
authors.forename: J R
authors.initials: JR
authors.lastname: Hardin
authors.forename: K L
authors.initials: KL
authors.lastname: Brigham
mesh_terms: D000818:Animals; D004347:Drug Interactions; D004731:Endotoxins / Q000037:antagonists & inhibitors / Q000633:toxicity*; D006098:Granulocytes / Q000187:drug effects / Q000378:metabolism; D006439:Hemodynamics / Q000187:drug effects; D066298:In Vitro Techniques; D011652:Pulmonary Circulation / Q000187:drug effects*; D012756:Sheep; D013481:Superoxides / Q000378:metabolism; D014115:Toxemia / Q000503:physiopathology; D014700:Verapamil / Q000494:pharmacology*; D014882:Water-Electrolyte Balance / Q000187:drug effects
chemical_list: D004731:Endotoxins; D013481:Superoxides; D014700:Verapamil